Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clindamycin phosphate

References

• Eschenbach DA. History and review of bacterial vaginosis. Am J Obstet Gynecol 1993;169:441–445.
   PubMed Web of Science ®Google Scholar
• Priestly CJF, Kinghorn GR. Bacterial vaginosis. Br J Clin Pract 1996;50:331–334.
   PubMedGoogle Scholar
• Mead PB. Epidemiology of bacterial vaginosis. Am J Obstet Gynecol 1993;169:446–449.
   PubMed Web of Science ®Google Scholar
• Schmid G, Markowitz L, Joesoef R, Koumans E. Bacterial vaginosis and HIV infection. Sex Transm Infect 2000;76:3–4.
   PubMed Web of Science ®Google Scholar
• Peipert J, Montagno A, Cooper A, Sung C. Bacterial vaginosis as a risk factor for upper genital tract. Am J Obstet Gynecol 1997;177:1184–1187.
   PubMed Web of Science ®Google Scholar
• Larsson P, Platz-Christensen J, Thejls H, Forsum U, Pahlson C. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: A double blind, randomized study. Am J Obstet Gynecol 1992;166:100–103.
   PubMed Web of Science ®Google Scholar
• Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Yang LP. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 1998;12:1699–1706.
   PubMed Web of Science ®Google Scholar
• Royce RA, Thorp J, Granados JL, Savitz DA. Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. J Acquir Immun Defic Syndr Hum Retrovirol 1999;20:382–386.
   PubMedGoogle Scholar
• Hillier SL. Treatment of bacterial vaginosis. Female Patient 1995;5:6–16.
   Google Scholar
• Joesoef MR, Schmid GP, Hillier SL. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999;28:S57–65.
   PubMed Web of Science ®Google Scholar
• Saracoglu F, Gol K, Sahin I, Turkkani B, Atalay C, Oztopcu C. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole. Int J Gynecol Obstet 1998;62:59–61.
   PubMed Web of Science ®Google Scholar
• Borin MT, Powley GW, Tackwell KR, Batts DH. Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream. J Antimicrob Chemother 1995;35:833–841.
   PubMed Web of Science ®Google Scholar
• Livengood CH, Thomason JL, Hill GB. Bacterial vaginosis: Treatment with topical intravaginal clindamycin phosphate. Obstet Gynecol 1990;76:118–123.
   PubMed Web of Science ®Google Scholar
• Eschenbach DA, Critchlow CW, Watkins H, Smith K, Spiegel CA, Chen KCS, Holmes KK. A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis (Suppl,) 1983;40:73–80.
   Google Scholar
• Greaves WL, Chungagung J, Morris B, Haile A, Townsend JL. Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1988;72:799–802.
   PubMed Web of Science ®Google Scholar
• Ahmed-Jusuf IH, Shahmanesh M, Arya OP. The treatment of bacterial vaginosis with a three day course of 2% clindamycin cream: Results of a multicentre, double blind, placebo controlled trial. Genitourin Med 1995;71:254–256.
   PubMedGoogle Scholar
• Rosenstein IJ, Morgan DJ, Lamont RF. Effect of vaginally applied clindamycin on vaginal microbial flora and outcome of pregnancy in women with bacterial vaginosis. Infect Dis Obstet Gynecol 2000;8:158–165.
   PubMedGoogle Scholar
• Ronald F, Lamont L, Brian MJ, Mandalay D, Philip EH, Marie S. The efficacy of vaginal clindamycin for the treatment of abnormal genital tract flora in pregnancy. Infect Dis Obstet Gynecol 2003;11:181–189.
   PubMedGoogle Scholar
• Paavonen J, Mangioni C, Martin MA, Wajszczuk CP,Vaginal clindamycin and oral metronidazole for bacterial vaginosis: A randomized trial. Obstet Gynecol 2000;96:256–260.
   PubMed Web of Science ®Google Scholar
• Andres FJ, Parker R, Hosein I, Benrubi GI. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: A prospective double-blind clinical trial. South Med J 1992;85:1077–1080.
   PubMed Web of Science ®Google Scholar
• Fischbach F, Petersen EE, Weissenbacher ER, Martius J, Hosmann J, Mayer H. Efficacy of clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 1993;82:405–410.
   PubMed Web of Science ®Google Scholar
• Vermani K, Garg S, Zaneveld LJD, Tambwekar KR. Survey of vaginal formulations available in Indian market; physico-chemical characterization of selected products. Int J Pharm Med 2002;16:141–152.
   Google Scholar
• Henderson MH, Couchman GM, Walmer DK, Peters JJ, Owen DH, Brown MA, Lavine ML, Katzab DF. Optical imaging and analysis of human vaginal coating by drug delivery gels. Contraception 2007;75:142–151.
   PubMedGoogle Scholar
• Ceschel GC, Maffei P, Barcia SL, Ronchi C, Rossi S. Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm 2001;27:541–547.
   PubMed Web of Science ®Google Scholar
• Kast CE, Valenta C, Leopold M, Bernkop-Schnürch A. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for CLT. J Cont Rel 2002;81:347–354.
   PubMed Web of Science ®Google Scholar
• Garg S, Kandarapu R, Vermani K, Tambwekar KR. Development pharmaceutics of microbicide formulations part I: Preformulation considerations and challenges. AIDS Patient Care STDS 2003;17:17–32.
   PubMed Web of Science ®Google Scholar
• Coggins C, Elias CJ, Atisook R, Bassett MT, Ghys PD, Jenkins-Woelk L, Thongkrajai E, Van Devanter NL. Women’s preferences regarding the formulation of over the counter vaginal spermicides. AIDS 1998;12:1389–1391.
   PubMed Web of Science ®Google Scholar
• Owen DH, Katz DF. A vaginal fluid stimulant. Contraception 1999;59:91–95.
   PubMed Web of Science ®Google Scholar
• Garg S, Vermani K, Garg A, Anderson RA, Rencher BW, Zaneveld LJD. Development and characterization of bioadheive vaginal films of sodium polystyrene sufonate (PSS), a novel contraceptive antimicrobial agent. Pharm Res 2005;22:584–595.
   PubMed Web of Science ®Google Scholar
• Mashru RC, Sutariya VB, Sankalia MG, Parikh PP. Development and evaluation of fast-dissolving film of salbutamol sulphate. Drug Dev Ind Pharm 2005;1:25–34.
   Google Scholar
• Derringer G, Suich R. Simultaneous optimization of several responses variables. J Quality Technol 1980;12:214–219.
   Web of Science ®Google Scholar
• Repka AM, McGinity JW. Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials 2000;21:509–1517.
   Google Scholar
• Peh KK, Wong CF. Polymeric films as vehicle for buccal delivery: Swelling, mechanical, and bioadhesive properties. J Pharmacy Pharm Sci 1999;2:53–61.
   PubMed Web of Science ®Google Scholar
• Gatti G, Malena M, Casazza R, Borin M, Bassetti M, Cruciani M. Penetration of clindamycin and its metabolite n-demethylclindamycin into cerebrospinal fluid following intravenous infusion of Clindamycin phosphate in patients with AIDS. J Antimicrob Chemother 1998;42:3014–3017.
   Google Scholar
• Jin-Wook Y, Dharmala K, Lee CH. The physicodynamic properties of bioadhesive polymeric films developed as female controlled drug delivery system. Int J Pharm 2006;309:139–141.
   PubMedGoogle Scholar
• Gannu R, Vishnu YV, Kishan V, Rao YM. Development of nitrendipine transdermal patches: in vitro and ex vivo characterization. Curr Drug Deliv 2007;4:69–76.
   PubMedGoogle Scholar
• Dobaria N, Mashru R, Vadia NH. Vaginal drug delivery systems: A review of current Status. East Cent Afr J Pharm Sci 2007;10:3–13.
   Google Scholar
• Alam MA, Ahmad FJ, Khan ZI, Khar RK, Ali M. Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections. AAPS PharmSciTech. 2007;8: Article 109.
   PubMedGoogle Scholar
• Lei W, Xing T. A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: Design, in vitro and ‘in vivo’ evaluation. Inter J Pharm 2008;350:181–187.
   PubMedGoogle Scholar
• Reddy KVR, Aranha C, Gupta SM, Yedery RD. Evaluation of antimicrobial peptide Nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 2004;128:117–126.
   PubMed Web of Science ®Google Scholar
• Korting HC, Schindler S, Hartinger A, Kerscher M, Maibatch HI. MTT assay and neutral red release (NRR) assay: Relative role in the prediction of the irritancy potential of surfactants. Life Sci 1994;55:533–540.
   PubMed Web of Science ®Google Scholar